Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 230, pseudogene (RN7SL230P)

Target
RN7SL230P
Molecular classification
Other
01

Overview

RN7SL230P is a processed pseudogene in the human genome similar to the 7SL RNA sequence, but it is truncated, mutated, and not expressed as a functional RNA. 7SL RNA itself is a non-coding RNA and an essential component of the signal recognition particle (SRP) for protein translocation, but RN7SL230P and the majority of 7SL pseudogenes have no coding potential and appear silent in cells. These loci arise from reverse transcription of 7SL RNA and insertion back into the genome, but are characterized by truncations, mutations, and poor conservation. Processed pseudogenes like RN7SL230P are not considered molecular targets for drug intervention, nor are they involved in cellular function or disease

Other names
RN7SL230P7SL RNA pseudogene7SL pseudogene (general)
02

Mechanism of action

None (not a drug target)

03

Biological functions

None (this locus is non-functional; canonical 7SL RNA is involved in SRP, but pseudogenes like RN7SL230P are not transcribed or play a biological role)
04

Disease associations

None (pseudogenes generally do not have direct disease involvement; no evidence links RN7SL230P to disease)
05

Safety considerations

None (no relevant safety data)
06

Interacting drugs

None (no known drugs interact with RN7SL230P)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 230, pseudogene (RN7SL230P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 230, pseudogene (RN7SL230P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call